Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Coala Life August monthly KPI’s USA

Coala-Life Group

KPI’s August 2023:

  • Patients in RPM as of August 31, 2023: 4,400
  • Annual revenue rate as of August 31, 2023: 5.2 MUSD

Explanations of KPI’s
Patients in RPM as of August 31, 2023 – Number of patients that the company monitors in USA at the end of August.
Annual revenue rate as of August 31, 2023 – Estimated recurring revenue in USD based on August month’s revenue, measured at an annual rate.

Comments of KPI’s August 2023
The August numbers were affected to a lesser extent by holiday times, even though Labor Day is the "official" end of summer in the US. Newly added clinics are now starting to contribute to more active patients.

Historical KPI’s

MonthPatients in RPMAnnual rate of turnover
August 20234,4005.2 MUSD
July 20234,1005.0 MUSD
June 20234,1005.6 MUSD
May 20233,8005.7 MUSD
April 20233,7005.4 MUSD
March 20233,7004.8 MUSD
February 20233,7004.6 MUSD
January 20233,8003.7 MUSD
December 20223,5003.6 MUSD
November 20223,1003.2 MUSD
October 20222,8003.2 MUSD
September 20222,6002.7 MUSD

The figures in this press release are preliminary and unaudited.

About us


Coala-Life Group AB (“Coala Life” or the “Company”) founded in 2015, is a Cloud Based Software as a Service provider, and medical device developer and reseller, listed on Nasdaq First North Growth Market. The Company focuses on B2B solutions for managed Remote Patient Monitoring (“RPM”), offering medical care providers, primarily in the US, with a highly scalable, cost-efficient platform to remotely and virtually manage large volumes of patients suffering from chronic diseases. The company offers care providers a comprehensive solution and lifts the administrative work from the care providers regarding, amongst other things, follow-up, 24/7 monitoring, as well as the reimbursement process from state and private health insurance companies. Patients are monitored long-term in everyday life and typically have diabetes, obesity, and/or cardiovascular disease. 
For more information see www.coalalife.com

For more information, please contact:


Dan Pitulia, CEO Coala Life AB
+44 7849 257 532, dan.pitulia@coalalife.com
Robin Danielsson Källmark, Interim CFO Coala Life AB
+46 72 188 84 09, robin.danielsson.kallmark@coalalife.com

Certified Adviser
The company's Certified Adviser is Erik Penser Bank AB.

Attachments


Coala Life August monthly KPI’s USA

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.